


020 7379 7799 | ask@blacagency.com | 1 Mercer Street, London, WC2H 9QJ | Map
Mundipharma International is a Cambridge-based company responsible for international licensing and business development activities in support of the Purdue/Mundipharma/Napp independent associated companies with emphasis on Europe.
Our challenge was to launch a new oncology drug called Levact with a simple proposition – “one drug, double impact”
BLAC developed a closely targeted campaign with a single-minded icon across specialist press and direct mail. A Pan European campaign was developed with the striking Newton’s cradle graphically demonstrating
the effect of the drugs on malignant cells.
Result: A successful European product launch supported by a campaign and extensive brand guidelines detailing how the campaign should be developed further for local adaptation.
Presentation slides
![]()